Literature DB >> 131783

Immune mechanism in Pasteurella multocida-infected mice.

J B Woolcock, F M Collins.   

Abstract

Various immunizing procedures were tested for their effect on the growth of Pasteurella multocida in specific pathogen-free CD-1 mice. Two injections with killed vaccine incorporated into Freund complete adjuvant gave excellent protection against parenteral challenge, but less to control the growth of an aerogenic inoculum. Protection with adjuvant-treated preparation was always superior to that seen with non-adjuvant-treated vaccines. A killed saline-suspended vaccine introduced aerogenically marginally increased resistance to small (2 to 5 mean lethal doses) aerogenic challenges. Live mycobacterium bovis (BCG) vaccine immunopotentiated a single dose of heat-killed P. multocida vaccine in terms of the protective immune response against a subsequent footpad challenge. Hyperimmune mouse serum, administered intraperitoneally, intramuscularly, or intravenously 1 to 7 days prior to subcutaneous challenge with 500 to 5,000 P. multocida, was highly protective. Mice injected in the thigh with 0.2 ml of hyperimmune serum prior to footpad challenge frequently developed a severe inflammatory response with local swelling within 48 h; these lesions often became severly abscessed with time. The passively protected, footpad-infected mice developed active immunity against a subsequent challenge given into the opposite footpad.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 131783      PMCID: PMC420699          DOI: 10.1128/iai.13.3.949-958.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice.

Authors:  F M Collins; M T Scott
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

2.  Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells.

Authors:  T E Miller; G B Mackaness; P H Lagrange
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

3.  Effect of adjuvant on immunogenicity of a heat-killed salmonella vaccine.

Authors:  F M Collins
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

Review 4.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

5.  Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

6.  Cell-mediated resistance to aerogenic infection of the lung.

Authors:  G L Truitt; G B Mackaness
Journal:  Am Rev Respir Dis       Date:  1971-12

7.  Relative immunogenicity of streptomycin-susceptible and -resistant strains of BCG. II. Effect of the route of inoculation on growth and immunogenicity.

Authors:  F M Collins; V Montalbine
Journal:  Am Rev Respir Dis       Date:  1975-01

8.  Growth of Pasteurella multocida in vaccinated and normal mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

9.  The pulmonary clearance of bacteria by calves and mice.

Authors:  L E Lillie; R G Thomson
Journal:  Can J Comp Med       Date:  1972-04

Review 10.  Pasteurellosis: Pasteurella multocida and Pasteurella hemolytica.

Authors:  G R Carter
Journal:  Adv Vet Sci       Date:  1967
View more
  6 in total

1.  Antibodies to outer membrane proteins but not to lipopolysaccharide inhibit pulmonary proliferation of Pasteurella multocida in mice.

Authors:  Y S Lu; H N Aguila; W C Lai; S P Pakes
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

Authors:  M Vasfi Marandi; K R Mittal
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  Inability of passively acquired antibody to protect lambs against experimental pasteurellosis.

Authors:  P W Wells; H B Evans; C Burrells; J M Sharp; N J Gilmour; D A Thompson; B Rushton
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

4.  Bactericidal activity of alveolar and peritoneal macrophages exposed in vitro to three strains of Pasteurella multocida.

Authors:  F M Collins; C J Niederbuhl; S G Campbell
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

5.  Hyperimmune serum from rabbits immunized with potassium thiocyanate extract of Pasteurella multocida protects against homologous challenge.

Authors:  Y S Lu; S P Pakes; L Massey
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

6.  Rapidly progressive and lethal septicemia due to infection with Pasteurella multocida in an infant.

Authors:  Johannes Haybaeck; Christoph Schindler; Paul Braza; Birgit Willinger; Marcus Drlicek
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.